With 11 reporting days into April, and 11 more to go, OGD has issued 25 full approval actions and 11 tentative approval actions for a total of 36 approval actions.  One application for VILAZODONE HYDROCHLORIDE was responsible for two actions (1 full approval and 1 tentative approval), as only one of its strengths was eligible for full approval.

If this rate continues for the rest of the month, we are heading for a total of 72 approval actions, which falls below the average total approval actions of 80.6 seen in the first 5 months of FY 2021.  We will report further on this after the month closes.